An lnRNA-H19 deficiency significantly protected mice from liver fibrosis in BDL and Mdr2−/− mice along with reduced HSC activation by cholangiocyte-derived, lnRNA-H19-deficient exosomes [146]. This evidence concerns the gene H19 and Hepatic fibrosis.